LIFECORE BIOMEDICAL, INC. Discontinued Operation, Tax Effect of Discontinued Operation
LIFECORE BIOMEDICAL, INC. (LFCR) reported Discontinued Operation, Tax Effect of Discontinued Operation of $0 for the 3-month period ending 2024-08-25, per its 10-Q filed 2024-10-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2024-10-04
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2024-08-25 was $0.00.
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2024-05-26 was -$3.00K.
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2024-02-25 was $3.00K.
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2023-11-26 was $24.00K.
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for fiscal 2024 was $18.00K.
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for fiscal 2023 was $0.00.
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for fiscal 2022 was -$690.00K.
- LIFECORE BIOMEDICAL, INC. discontinued operation, tax effect of discontinued operation for fiscal 2021 was -$1.43M.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 3 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 12 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-08-25 | $0.00 10-Q · filed 2024-10-04 | -$3.00K derived: sum of 2 quarters · filed 2024-10-04 | $0.00 derived: sum of 3 quarters · filed 2024-10-04 | $24.00K derived: sum of 4 quarters · filed 2024-10-04 | |||
| 2024-05-26 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $0.00 derived: sum of 2 quarters · filed 2024-08-26 | $24.00K derived: sum of 3 quarters · filed 2024-08-26 | $18.00K 10-K · filed 2024-08-26 | |||
| 2024-02-25 | $3.00K 10-Q · filed 2024-08-09 | $27.00K derived: sum of 2 quarters · filed 2024-08-09 | $21.00K 10-Q · filed 2024-08-09 | $21.00K derived: sum of 4 quarters · filed 2024-10-04 | |||
| 2023-11-26 | $24.00K 10-Q · filed 2024-08-09 | $18.00K 10-Q · filed 2024-08-09 | $18.00K derived: sum of 3 quarters · filed 2024-10-04 | $18.00K derived: sum of 4 quarters · filed 2024-10-04 | |||
| 2023-08-27 | -$6.00K 10-Q · filed 2024-10-04 | -$6.00K derived: sum of 2 quarters · filed 2024-10-04 | -$6.00K derived: sum of 3 quarters · filed 2024-10-04 | -$6.00K derived: sum of 4 quarters · filed 2024-10-04 | |||
| 2023-05-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $0.00 derived: sum of 2 quarters · filed 2024-08-26 | $0.00 derived: sum of 3 quarters · filed 2024-08-26 | $0.00 10-K · filed 2024-08-26 | |||
| 2023-02-26 | $0.00 10-Q · filed 2024-08-09 | $0.00 derived: sum of 2 quarters · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | -$847.00K derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-11-27 | $0.00 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | -$847.00K derived: sum of 3 quarters · filed 2024-08-26 | -$4.73M derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-08-28 | $0.00 10-Q · filed 2024-08-09 | -$847.00K derived: sum of 2 quarters · filed 2024-08-26 | -$4.73M derived: sum of 3 quarters · filed 2024-08-26 | -$1.31M derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-05-29 | -$847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | -$4.73M derived: sum of 2 quarters · filed 2024-08-26 | -$1.31M derived: sum of 3 quarters · filed 2024-08-26 | -$690.00K 10-K · filed 2024-08-26 | -$121.00K 10-K · filed 2022-09-14 | ||
| 2022-02-27 | -$3.89M 10-K · filed 2024-03-20 | -$411.00K 10-Q · filed 2023-06-02 | -$459.00K derived: sum of 2 quarters · filed 2024-03-20 | $157.00K 10-Q · filed 2023-06-02 | |||
| 2021-11-28 | $3.43M 10-K · filed 2024-03-20 | $261.00K 10-Q · filed 2023-03-16 | -$200.00K 10-Q · filed 2023-03-16 | ||||
| 2021-08-29 | -$282.00K 10-K · filed 2024-03-20 | ||||||
| 2021-05-30 | -$1.43M 10-K · filed 2024-03-20 | $0.00 10-K · filed 2021-07-29 | |||||
| 2021-02-28 | $923.00K 10-K · filed 2024-03-20 | $119.00K derived: sum of 2 quarters · filed 2024-03-20 | -$700.00K derived: sum of 3 quarters · filed 2024-03-20 | -$5.04M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-11-29 | -$804.00K 10-K · filed 2024-03-20 | -$1.62M derived: sum of 2 quarters · filed 2024-03-20 | -$5.96M derived: sum of 3 quarters · filed 2024-03-20 | -$5.96M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-08-30 | -$819.00K 10-K · filed 2024-03-20 | -$5.16M derived: sum of 2 quarters · filed 2024-03-20 | -$5.16M derived: sum of 3 quarters · filed 2024-03-20 | -$5.16M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-05-31 | -$4.34M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | -$4.34M derived: sum of 2 quarters · filed 2023-03-16 | -$4.34M derived: sum of 3 quarters · filed 2023-03-16 | -$4.34M 10-K/A · filed 2023-03-16 | $0.00 10-K · filed 2020-08-14 | ||
| 2020-02-23 | $0.00 10-Q · filed 2020-04-03 | $0.00 derived: sum of 2 quarters · filed 2020-04-03 | $0.00 10-Q · filed 2020-04-03 | -$194.00K derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2019-11-24 | $0.00 10-Q · filed 2020-01-02 | $0.00 10-Q · filed 2020-01-02 | -$194.00K derived: sum of 3 quarters · filed 2021-07-29 | -$337.00K derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2019-08-25 | $0.00 10-Q · filed 2019-10-03 | -$194.00K derived: sum of 2 quarters · filed 2021-07-29 | -$337.00K derived: sum of 3 quarters · filed 2021-07-29 | -$482.00K derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2019-05-26 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | -$337.00K derived: sum of 2 quarters · filed 2021-07-29 | -$482.00K derived: sum of 3 quarters · filed 2021-07-29 | -$527.00K 10-K · filed 2021-07-29 | |||
| 2019-02-24 | -$143.00K 10-Q · filed 2020-04-03 | $0.00 10-Q · filed 2019-04-04 | -$288.00K derived: sum of 2 quarters · filed 2020-04-03 | -$333.00K 10-Q · filed 2020-04-03 | $0.00 10-Q · filed 2019-04-04 | -$583.00K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-11-25 | -$145.00K 10-Q · filed 2020-01-02 | -$190.00K 10-Q · filed 2020-01-02 | -$440.00K derived: sum of 3 quarters · filed 2020-08-14 | -$522.00K derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2018-08-26 | -$45.00K 10-Q · filed 2019-10-03 | -$295.00K derived: sum of 2 quarters · filed 2020-08-14 | -$377.00K derived: sum of 3 quarters · filed 2020-08-14 | -$335.00K derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2018-05-27 | -$250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | -$332.00K derived: sum of 2 quarters · filed 2020-08-14 | -$290.00K derived: sum of 3 quarters · filed 2020-08-14 | -$350.00K 10-K · filed 2020-08-14 | |||
| 2018-02-25 | -$82.00K 10-Q · filed 2019-04-04 | -$40.00K derived: sum of 2 quarters · filed 2019-04-04 | -$100.00K 10-Q · filed 2019-04-04 | ||||
| 2017-11-26 | $42.00K 10-Q · filed 2019-01-07 | -$18.00K 10-Q · filed 2019-01-07 | |||||
| 2017-08-27 | -$60.00K 10-Q · filed 2018-10-05 | ||||||
| 2017-05-28 | $295.00K 10-K · filed 2019-08-01 | ||||||
| 2016-05-29 | $300.00K 10-K · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |